We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

MaxCyte

Consistent solid delivery

Update | 19 September 2019

Nexstim

Voluntary loan repayments remove Kreos uncertainty

Lighthouse | 17 September 2019

Hutchison China MediTech

WCLC 2019: detailed FALUCA data disclosed

Update | 11 September 2019

Scancell

A sweet source of financing

Update | 04 September 2019

Scancell

SCIB1 Phase II study starts in UK

Update | 21 August 2019

Nexstim

Promising progress with NBT

Update | 20 August 2019

BerGenBio

Refining the route ahead

Lighthouse | 20 August 2019

e-therapeutics

Second agreement helps validate capabilities

Lighthouse | 13 August 2019

Hutchison China MediTech

Carrying momentum into H219

Update | 13 August 2019

Bonesupport

All eyes on Q3 following a record Q2

Update | 31 July 2019
1 2 3 4 5 6 7 8 9 10 11 12 13 14
136 results found.